External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS, Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report No. 50), ICRU Report No. 62, ICRU, Bethesda, MD (1999) ...

Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.

Will I be radioactive after radiotherapy? External beam radiotherapy does not make patients radioactive. Patients who receive radioactive implants (brachytherapy) or radionuclide therapy might be ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

His medical records show he picked brachytherapy, rather than external beam radiation or surgery. He was unaware that brachytherapy errors at the Philadelphia V.A. were piling up. Rev. Ricardo ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

Radiation therapy is a cancer treatment that uses high doses of radiation to kill cancer cells Read on to learn how ...

You can’t have this treatment if your melanoma is too thick. This is because the radiation would not reach all the cancer. In this case, you would have external beam radiotherapy instead. Plaque ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...